TA29 Leukaemia (lymphocytic) - fludarabine: Guidance

Oral fludarabine is recommended as second line therapy for B-cell chronic lymphocytic leukaemia (CLL) for patients who have failed, or are intolerant of, first line chemotherapy, and who would otherwise have received combination chemotherapy.